SINGAPORE – All 71 mosques here will be backing an anti-drug campaign this year, with a specially crafted sermon encouraging the community to play an active role. The Dadah Itu […]
SINGAPORE – Researchers in Singapore have developed a blood test which will not only allow doctors to determine the effectiveness of cancer treatment within 24 hours, but also detect the […]
HONG KONG, May 24, 2021 – (ACN Newswire via SEAPRWire.com) – Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology” or the “Company”; stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, […]
SHANGHAI, CHINA, Apr 23, 2021 – (ACN Newswire via SEAPRWire.com) – Hua Medicine (the “Company”, Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the […]
SINGAPORE – Singapore intends to run for membership in the United Nations Commission on Narcotic Drugs (CND), the main drug policymaking body of the UN. Membership will be for the […]
TOKYO, Apr 7, 2021 – (JCN Newswire via SEAPRWire.com) – Hitachi, Ltd. (TSE:6501) and Axcelead, Inc. today announced that they have agreed on a comprehensive collaborative partnership to develop solutions […]
SINGAPORE – The Singapore Government has registered its disappointment at a United Nation commission’s reclassification of cannabis as a less dangerous drug, saying this could fuel the wrong perception that […]
TOKYO, Nov 30, 2020 – (JCN Newswire) – Eisai Co., Ltd. and Wren Therapeutics Ltd. today announced that the companies have entered into an exclusive research collaboration agreement aiming to […]
SINGAPORE – Two young mothers, aged 19 and 26, were using drugs in front of their five-year-old and four-month-old children when officers from the Central Narcotics Bureau (CNB) raided the […]
TOKYO, Nov 13, 2020 – (JCN Newswire) – PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (TSE:4587), Fujitsu Limited (TSE:6702), Mizuho Capital Co., Ltd. which is a consolidated subsidiary of Mizuho […]
SHANGHAI, CHINA, Oct 14, 2020 – (ACN Newswire) – Hua Medicine (the “Company”, Stock Code: 2552.HK) announces that, after review and on-site verification under the Marketing Authorization Holder (“MAH”) system, […]
